These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10742708)

  • 1. A comparison of intervention with losartan or captopril in acute myocardial infarction.
    Spinar J; Vitovec J; Spinarova L; Pluhacek L; Fischerova B; Toman J
    Eur J Heart Fail; 2000 Mar; 2(1):91-100. PubMed ID: 10742708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
    Møller JE; Dahlström U; Gøtzsche O; Lahiri A; Skagen K; Andersen GS; Egstrup K;
    Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study.
    Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Giubilato A; Paterna S
    Heart; 1999 Jun; 81(6):606-11. PubMed ID: 10336919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J;
    Lancet; 2002 Sep; 360(9335):752-60. PubMed ID: 12241832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J
    Am J Cardiol; 1999 Feb; 83(4):477-81. PubMed ID: 10073846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction.
    Spinar J; Vitovec J; Pluhacek L; Spinarova L; Fischerova B; Toman J
    Int J Cardiol; 2000 Sep; 75(2-3):197-204. PubMed ID: 11077134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
    Konermann M; Odenthal HJ; Altmann C; Laschewski F; Rawert B; Trappe HJ; Sanner BM
    Wien Med Wochenschr; 2000; 150(12):249-55. PubMed ID: 11008329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction?
    Doggrell SA
    Expert Opin Pharmacother; 2003 Mar; 4(3):407-9. PubMed ID: 12614193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril adjuvant therapy to beta-blockers and nitrates improves post-myocardial infarction left ventricular performance.
    Kyriakidis M; Antonopoulos A; Georgiou E; Santas P; Bakirtzis C; Toutouzas P
    Eur Heart J; 1996 Jun; 17(6):864-73. PubMed ID: 8781825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade.
    Youn TJ; Kim HS; Oh BH
    Basic Res Cardiol; 1999 Aug; 94(4):246-53. PubMed ID: 10505424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after myocardial infarction in rats: captopril versus losartan.
    Milavetz JJ; Raya TE; Johnson CS; Morkin E; Goldman S
    J Am Coll Cardiol; 1996 Mar; 27(3):714-9. PubMed ID: 8606287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.
    Maia LN; Nicolau JC; Vítola JV; Santos M; Brandi JM; Joaquim MR; Baggi JM; Cordeiro JA; de Godoy MF
    Am Heart J; 2003 Jun; 145(6):E21. PubMed ID: 12796769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling].
    Mill JG; Milanez Mda C; Busatto VC; de Moraes AC; Gomes Mda G
    Arq Bras Cardiol; 1997 Aug; 69(2):101-10. PubMed ID: 9567332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the tissue affinity of ACE inhibitors of relevance for the remodeling of the left ventricular wall following myocardial infarction? Estimations with cine magnetic resonance imaging.
    Konermann M; Sanner BM; Altmann C; Laschewski F; Rawert B; Trappe HJ
    Cardiology; 2000; 94(3):179-87. PubMed ID: 11279324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study.
    Di Pasquale P; Bucca V; Scalzo S; Paterna S
    Cardiovasc Drugs Ther; 1998 May; 12(2):211-6. PubMed ID: 9652880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
    Konermann M; Altmann C; Laschewski F; Josephs W; Odenthal HJ; Horstmann E; Sanner B
    Clin Cardiol; 1998 Apr; 21(4):277-85. PubMed ID: 9562938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction.
    Onodera H; Matsunaga T; Tamura Y; Maeda N; Higuma T; Sasaki S; Mori Y; Yoshimachi F; Ishizaka H; Hanada H; Osanai T; Okumura K
    Am Heart J; 2005 Oct; 150(4):689. PubMed ID: 16209966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of losartan and captopril on ventricular remodeling and function after myocardial infarction in the rat.
    Zhang G; Shen X; Pu S; Yang Y; Pan W; Chen H
    Chin Med Sci J; 1998 Mar; 13(1):32-6. PubMed ID: 11717921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.